Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity

Autor: Edurne Berra, Paul N. Moynagh, Jacques Pouysségur, Cormac T. Taylor, Amandine Ginouvès, Katrina M. Comerford, Kathleen T. Fitzgerald, Jens Erik Nielsen, Catherine Godson, Fergal Seeballuck, Eoin P. Cummins
Přispěvatelé: Conway Institute of Biomolecular and Biomedical Research, University College Dublin [Dublin] (UCD), Institut de signalisation, biologie du développement et cancer (ISBDC), Centre National de la Recherche Scientifique (CNRS)-Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)
Rok vydání: 2006
Předmět:
MESH: Cell Nucleus
Molecular Sequence Data
MESH: Cell Hypoxia
Procollagen-Proline Dioxygenase
MESH: NF-kappa B
[SDV.CAN]Life Sciences [q-bio]/Cancer
MESH: Amino Acid Sequence
IκB kinase
Biology
Cell Line
Hydroxylation
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
medicine
Humans
MESH: Protein Binding
[SDV.BBM]Life Sciences [q-bio]/Biochemistry
Molecular Biology

Amino Acid Sequence
MESH: I-kappa B Kinase
Transcription factor
030304 developmental biology
Cell Nucleus
0303 health sciences
MESH: Humans
MESH: Molecular Sequence Data
Multidisciplinary
Tumor Necrosis Factor-alpha
NF-kappa B
I-Kappa-B Kinase
Biological Sciences
Hypoxia (medical)
Molecular biology
Cell Hypoxia
I-kappa B Kinase
MESH: Cell Line
Cell biology
IκBα
chemistry
MESH: Tumor Necrosis Factor-alpha
030220 oncology & carcinogenesis
Procollagen-proline dioxygenase
medicine.symptom
Signal transduction
Protein Binding
MESH: Procollagen-Proline Dioxygenase
Zdroj: Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2006, 103 (48), pp.18154-9. ⟨10.1073/pnas.0602235103⟩
ISSN: 1091-6490
0027-8424
Popis: Hypoxia is a feature of the microenvironment of a growing tumor. The transcription factor NFkappaB is activated in hypoxia, an event that has significant implications for tumor progression. Here, we demonstrate that hypoxia activates NFkappaB through a pathway involving activation of IkappaB kinase-beta (IKKbeta) leading to phosphorylation-dependent degradation of IkappaBalpha and liberation of NFkappaB. Furthermore, through increasing the pool and/or activation potential of IKKbeta, hypoxia amplifies cellular sensitivity to stimulation with TNFalpha. Within its activation loop, IKKbeta contains an evolutionarily conserved LxxLAP consensus motif for hydroxylation by prolyl hydroxylases (PHDs). Mimicking hypoxia by treatment of cells with siRNA against PHD-1 or PHD-2 or the pan-prolyl hydroxylase inhibitor DMOG results in NFkappaB activation. Conversely, overexpression of PHD-1 decreases cytokine-stimulated NFkappaB reporter activity, further suggesting a repressive role for PHD-1 in controlling the activity of NFkappaB. Hypoxia increases both the expression and activity of IKKbeta, and site-directed mutagenesis of the proline residue (P191A) of the putative IKKbeta hydroxylation site results in a loss of hypoxic inducibility. Thus, we hypothesize that hypoxia releases repression of NFkappaB activity through decreased PHD-dependent hydroxylation of IKKbeta, an event that may contribute to tumor development and progression through amplification of tumorigenic signaling pathways.
Databáze: OpenAIRE